Ingrasciotta, Ylenia
Ingrasciotta, Ylenia
Dipartimento di Scienze biomediche, odontoiatriche e delle immagini morfologiche e funzionali
1. Real World Evidence vs. Real World Data: definizioni e razionale
2019-01-01 Trifiro', Gianluca; Ingrasciotta, Ylenia
12. Real World Evidence nelle valutazioni post‑marketing su farmaci generici e biosimilari
2019-01-01 Ingrasciotta, Ylenia; Trifiro', Gianluca
Adverse drug reactions associated with off-label use of ketorolac, with particular focus on elderly patients. An analysis of the Italian pharmacovigilance database and a population based study
2016-01-01 E., Viola; Trifirò, G.; Ingrasciotta, Ylenia; Sottosanti, Laura; M., Tari; Giorgianni, Francesco; U., Moretti; R., Leone
Analgesic drug use in elderly persons: A population-based study in Southern Italy
2019-01-01 Ingrasciotta, Y.; Sultana, J.; Giorgianni, F.; Menditto, E.; Scuteri, A.; Tari, M.; Tari, D. U.; Basile, G.; Trifiro, G.
Antidepressants and the Risk of Cardiovascular Events in Elderly Affected by Cardiovascular Disease: A Real-Life Investigation From Italy
2020-01-01 Biffi, Annalisa; Rea, Federico; Scotti, Lorenza; Lucenteforte, Ersilia; Vannacci, Alfredo; Lombardi, Niccolò; Chinellato, Alessandro; Onder, Graziano; Vitale, Cristiana; Cascini, Silvia; Ingrasciotta, Ylenia; Roberto, Giuseppe; Mugelli, Alessandro; Corrao, Giovanni
Are Patients with Psoriasis and Psoriatic Arthritis Undertreated? A Population-Based Study from Southern Italy
2021-01-01 Ingrasciotta, Ylenia; Isgrò, Valentina; Ientile, Valentina; Tari, Michele; Trifirò, Gianluca; Guarneri, Claudio
Association of individual non-steroidal anti-inflammatory drugs and chronic kidney disease: a population-based case control study
2015-01-01 Ingrasciotta, Ylenia; Sultana, Janet; Giorgianni, Francesco; Fontana, Andrea; Santangelo, Antonio; Tari, Daniele Ugo; Santoro, Domenico; Arcoraci, Vincenzo; Perrotta, Margherita; Ibanez, Luisa; Trifiro', Gianluca
Biosimilars in Italy: What do real-world data reveal?
2017-01-01 Trifiro, G.; Ingrasciotta, Y.; Marciano, I.; Genazzani, A.
Cancer Patients at Risk for Medication-Related Osteonecrosis of the Jaw. A Case and Control Study Analyzing Predictors of MRONJ Onset
2021-01-01 Marcianò, Antonia; Ingrasciotta, Ylenia; Isgrò, Valentina; L'Abbate, Luca; Foti, Saveria Serena; Picone, Antonio; Peditto, Matteo; Guzzo, Gian Marco; Alibrandi, Angela; Oteri, Giacomo
Challenges in Post-marketing Studies of Biological Drugs in the Era of Biosimilars: A Report of the International Society for Pharmacoepidemiology 2019 Mid-Year Meeting in Rome, Italy
2019-01-01 Ingrasciotta, Y.; Sultana, J.; Kirchmayer, U.; Trifiro, G.
Characteristics and Absolute Survival of Metastatic Colorectal Cancer Patients Treated With Biologics: A Real-World Data Analysis From Three European Countries
2021-01-01 Oppelt, K. A.; Kuiper, J. G.; Ingrasciotta, Y.; Ientile, V.; Herings, R. M. C.; Tari, M.; Trifiro, G.; Haug, U.
Chronic Kidney Disease Requiring Healthcare Services: A New Approach to Evaluate Epidemiology of Renal Disease
2014-01-01 Gianluca Trifirò;Janet Sultana;Francesco Giorgianni;Ylenia Ingrasciotta;Michele Buemi;Marco Muscianisi;Daniele Ugo Tari;Margherita Perrotta;Valeria Canale;Vincenzo Arcoraci;Domenico Santoro
Comparative Effectiveness of Biosimilar, Reference Product and Other Erythropoiesis-Stimulating Agents (ESAs) Still Covered by Patent in Chronic Kidney Disease and Cancer Patients: An Italian Population-Based Study
2016-01-01 Ingrasciotta, Ylenia; Giorgianni, Francesco; Marcianò, Ilaria; Bolcato, Jenny; Pirolo, Roberta; Chinellato, Alessandro; Ientile, Valentina; Santoro, Domenico; Genazzani, Armando A.; Alibrandi, Angela; Fontana, Andrea; Caputi, Achille; Trifiro', Gianluca
Comparison of Direct Oral Anticoagulant Use for the Treatment of Non-Valvular Atrial Fibrillation in Pivotal Clinical Trials vs. the Real-World Setting: A Population-Based Study from Southern Italy
2021-01-01 Ingrasciotta, Ylenia; Fontana, Andrea; Mancuso, Anna; Ientile, Valentina; Sultana, Janet; Uomo, Ilaria; Pastorello, Maurizio; Calabrò, Paolo; Andò, Giuseppe; Trifirò, Gianluca
Direct healthcare costs of chronic kidney disease management in Italy: What cost-savings can be achieved with higher biosimilar uptake and more appropriate use of erythropoiesis-stimulating agents?
2021-01-01 Ingrasciotta, Y.; Sultana, J.; Formica, D.; Ientile, V.; Aiello, A.; Chinellato, A.; Tari, D. U.; Gini, R.; Pastorello, M.; Scondotto, S.; Cananzi, P.; Traversa, G.; Rossi, M.; Santoro, D.; Trifiro, G.
Effectiveness and Safety of Switching Originator and Biosimilar Epoetins in Patients with Chronic Kidney Disease in a Large-Scale Italian Cohort Study
2019-01-01 Belleudi, V.; Trotta, F.; Addis, A.; Ingrasciotta, Y.; Ientile, V.; Tari, M.; Gini, R.; Pastorello, M.; Scondotto, S.; Cananzi, P.; Traversa, G.; Davoli, M.; Trifiro, G.; Caputi, A. P.; Giorgianni, F.; Marciano, I.; Chinellato, A.; Bolcato, J.; Pirolo, R.; Roberto, G.; Genazzani, A. A.; Uomo, I.; Addario, S. W. P.; Da Cas, R.; Rossi, M.; Belleudi, V.
Efficacy of Systemic Biologic Drugs in Pediatric Psoriasis: Evidence From Five Selected Randomized Clinical Trials
2022-01-01 Di Lernia, Vito; Macca, Laura; Peterle, Lucia; Ingrasciotta, Ylenia; Trifirò, Gianluca; Guarneri, Claudio
Erratum: In search of potential predictors of erythropoiesis-stimulating agents (ESAs) hyporesponsiveness: A population-based study (BMC Nephrology (2019) 20 (359) DOI: 10.1186/s12882-019-1554-0)
2020-01-01 Ingrasciotta, Y.; Lacava, V.; Marciano, I.; Giorgianni, F.; Tripepi, G.; Arrigo, G. D.; Chinellato, A.; Tari, D. U.; Santoro, D.; Trifiro, G.
Hidradenitis suppurativa and psoriasis: the odd couple
2023-01-01 Macca, Laura; Li Pomi, Federica; Ingrasciotta, Ylenia; Morrone, Pietro; Trifirò, Gianluca; Guarneri, Claudio
Hidradenitis Suppurativa in Patients with HIV: A Scoping Review
2022-01-01 Macca, Laura; Moscatt, Vittoria; Ceccarelli, Manuela; Ingrasciotta, Ylenia; Nunnari, Giuseppe; Guarneri, Claudio
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 1. Real World Evidence vs. Real World Data: definizioni e razionale | 1-gen-2019 | Trifiro', Gianluca; Ingrasciotta, Ylenia | |
| 12. Real World Evidence nelle valutazioni post‑marketing su farmaci generici e biosimilari | 1-gen-2019 | Ingrasciotta, Ylenia; Trifiro', Gianluca | |
| Adverse drug reactions associated with off-label use of ketorolac, with particular focus on elderly patients. An analysis of the Italian pharmacovigilance database and a population based study | 1-gen-2016 | E., Viola; Trifirò, G.; Ingrasciotta, Ylenia; Sottosanti, Laura; M., Tari; Giorgianni, Francesco; U., Moretti; R., Leone | |
| Analgesic drug use in elderly persons: A population-based study in Southern Italy | 1-gen-2019 | Ingrasciotta, Y.; Sultana, J.; Giorgianni, F.; Menditto, E.; Scuteri, A.; Tari, M.; Tari, D. U.; Basile, G.; Trifiro, G. | |
| Antidepressants and the Risk of Cardiovascular Events in Elderly Affected by Cardiovascular Disease: A Real-Life Investigation From Italy | 1-gen-2020 | Biffi, Annalisa; Rea, Federico; Scotti, Lorenza; Lucenteforte, Ersilia; Vannacci, Alfredo; Lombardi, Niccolò; Chinellato, Alessandro; Onder, Graziano; Vitale, Cristiana; Cascini, Silvia; Ingrasciotta, Ylenia; Roberto, Giuseppe; Mugelli, Alessandro; Corrao, Giovanni | |
| Are Patients with Psoriasis and Psoriatic Arthritis Undertreated? A Population-Based Study from Southern Italy | 1-gen-2021 | Ingrasciotta, Ylenia; Isgrò, Valentina; Ientile, Valentina; Tari, Michele; Trifirò, Gianluca; Guarneri, Claudio | |
| Association of individual non-steroidal anti-inflammatory drugs and chronic kidney disease: a population-based case control study | 1-gen-2015 | Ingrasciotta, Ylenia; Sultana, Janet; Giorgianni, Francesco; Fontana, Andrea; Santangelo, Antonio; Tari, Daniele Ugo; Santoro, Domenico; Arcoraci, Vincenzo; Perrotta, Margherita; Ibanez, Luisa; Trifiro', Gianluca | |
| Biosimilars in Italy: What do real-world data reveal? | 1-gen-2017 | Trifiro, G.; Ingrasciotta, Y.; Marciano, I.; Genazzani, A. | |
| Cancer Patients at Risk for Medication-Related Osteonecrosis of the Jaw. A Case and Control Study Analyzing Predictors of MRONJ Onset | 1-gen-2021 | Marcianò, Antonia; Ingrasciotta, Ylenia; Isgrò, Valentina; L'Abbate, Luca; Foti, Saveria Serena; Picone, Antonio; Peditto, Matteo; Guzzo, Gian Marco; Alibrandi, Angela; Oteri, Giacomo | |
| Challenges in Post-marketing Studies of Biological Drugs in the Era of Biosimilars: A Report of the International Society for Pharmacoepidemiology 2019 Mid-Year Meeting in Rome, Italy | 1-gen-2019 | Ingrasciotta, Y.; Sultana, J.; Kirchmayer, U.; Trifiro, G. | |
| Characteristics and Absolute Survival of Metastatic Colorectal Cancer Patients Treated With Biologics: A Real-World Data Analysis From Three European Countries | 1-gen-2021 | Oppelt, K. A.; Kuiper, J. G.; Ingrasciotta, Y.; Ientile, V.; Herings, R. M. C.; Tari, M.; Trifiro, G.; Haug, U. | |
| Chronic Kidney Disease Requiring Healthcare Services: A New Approach to Evaluate Epidemiology of Renal Disease | 1-gen-2014 | Gianluca Trifirò;Janet Sultana;Francesco Giorgianni;Ylenia Ingrasciotta;Michele Buemi;Marco Muscianisi;Daniele Ugo Tari;Margherita Perrotta;Valeria Canale;Vincenzo Arcoraci;Domenico Santoro | |
| Comparative Effectiveness of Biosimilar, Reference Product and Other Erythropoiesis-Stimulating Agents (ESAs) Still Covered by Patent in Chronic Kidney Disease and Cancer Patients: An Italian Population-Based Study | 1-gen-2016 | Ingrasciotta, Ylenia; Giorgianni, Francesco; Marcianò, Ilaria; Bolcato, Jenny; Pirolo, Roberta; Chinellato, Alessandro; Ientile, Valentina; Santoro, Domenico; Genazzani, Armando A.; Alibrandi, Angela; Fontana, Andrea; Caputi, Achille; Trifiro', Gianluca | |
| Comparison of Direct Oral Anticoagulant Use for the Treatment of Non-Valvular Atrial Fibrillation in Pivotal Clinical Trials vs. the Real-World Setting: A Population-Based Study from Southern Italy | 1-gen-2021 | Ingrasciotta, Ylenia; Fontana, Andrea; Mancuso, Anna; Ientile, Valentina; Sultana, Janet; Uomo, Ilaria; Pastorello, Maurizio; Calabrò, Paolo; Andò, Giuseppe; Trifirò, Gianluca | |
| Direct healthcare costs of chronic kidney disease management in Italy: What cost-savings can be achieved with higher biosimilar uptake and more appropriate use of erythropoiesis-stimulating agents? | 1-gen-2021 | Ingrasciotta, Y.; Sultana, J.; Formica, D.; Ientile, V.; Aiello, A.; Chinellato, A.; Tari, D. U.; Gini, R.; Pastorello, M.; Scondotto, S.; Cananzi, P.; Traversa, G.; Rossi, M.; Santoro, D.; Trifiro, G. | |
| Effectiveness and Safety of Switching Originator and Biosimilar Epoetins in Patients with Chronic Kidney Disease in a Large-Scale Italian Cohort Study | 1-gen-2019 | Belleudi, V.; Trotta, F.; Addis, A.; Ingrasciotta, Y.; Ientile, V.; Tari, M.; Gini, R.; Pastorello, M.; Scondotto, S.; Cananzi, P.; Traversa, G.; Davoli, M.; Trifiro, G.; Caputi, A. P.; Giorgianni, F.; Marciano, I.; Chinellato, A.; Bolcato, J.; Pirolo, R.; Roberto, G.; Genazzani, A. A.; Uomo, I.; Addario, S. W. P.; Da Cas, R.; Rossi, M.; Belleudi, V. | |
| Efficacy of Systemic Biologic Drugs in Pediatric Psoriasis: Evidence From Five Selected Randomized Clinical Trials | 1-gen-2022 | Di Lernia, Vito; Macca, Laura; Peterle, Lucia; Ingrasciotta, Ylenia; Trifirò, Gianluca; Guarneri, Claudio | |
| Erratum: In search of potential predictors of erythropoiesis-stimulating agents (ESAs) hyporesponsiveness: A population-based study (BMC Nephrology (2019) 20 (359) DOI: 10.1186/s12882-019-1554-0) | 1-gen-2020 | Ingrasciotta, Y.; Lacava, V.; Marciano, I.; Giorgianni, F.; Tripepi, G.; Arrigo, G. D.; Chinellato, A.; Tari, D. U.; Santoro, D.; Trifiro, G. | |
| Hidradenitis suppurativa and psoriasis: the odd couple | 1-gen-2023 | Macca, Laura; Li Pomi, Federica; Ingrasciotta, Ylenia; Morrone, Pietro; Trifirò, Gianluca; Guarneri, Claudio | |
| Hidradenitis Suppurativa in Patients with HIV: A Scoping Review | 1-gen-2022 | Macca, Laura; Moscatt, Vittoria; Ceccarelli, Manuela; Ingrasciotta, Ylenia; Nunnari, Giuseppe; Guarneri, Claudio |